Papers
1
Total Citations
160
H-Index
1
About
Dr. Jane Zhao is a pioneering biochemist whose work has fundamentally advanced the field of high-throughput drug discovery, particularly for protein kinases and phosphatases—key regulators of cell signaling, proliferation, and metabolism. Her landmark 2002 paper, "A FRET-Based Assay Platform for Ultra-High Density Drug Screening of Protein Kinases and Phosphatases," has garnered over 160 citations, establishing a transformative methodology for identifying therapeutic compounds. By harnessing fluorescence resonance energy transfer (FRET), Zhao created a robust, miniaturized assay that enables the rapid screening of millions of compounds against these critical enzymes, which are often dysregulated in diseases like cancer. This innovation dramatically accelerated the early stages of drug development, providing researchers with a reliable, high-sensitivity tool to probe aberrant kinase and phosphatase activity. Her work bridges fundamental cell biology and practical pharmacology, offering a platform that has been widely adopted in both academic and pharmaceutical settings. Dr. Zhao’s contributions have not only deepened our understanding of signal-induced cellular events but also paved the way for novel targeted therapies, making her a key figure in modern chemical biology and drug discovery.
Research Focus
Key Achievements
Top Papers
- 1